Tim
28 Mar '13
Too late, he must have been furious, he sold £51.91
RE: Tim,
28 Mar '13
And if he doesn't do as you say, that £27.85 buy is going to get sold so you've been warned!
baton rouge
28 Mar '13
They'll be on @ reduced to clear after Easter, I want a full value RNS. (We've had our 1/2 price).
ATVB
KR
ZA
Tim,
28 Mar '13
when the market reopens next week, I`d like an easter egg rns from sar. Not a mickey mouse smarties easter egg, but a huge one in a basket. With little fluffy bunnies at the front. We know you can hear us Tim........ make a name for yourself in April....... a huge easter egg rns.... like the one my missus demands
Short
28 Mar '13
For me they could opened the short prior to the drawdown, they'd be significantly closer to the time lines in play.
Once the news came, they could've closed the short, the gain (made by closing the short) would have also pushed the price up and compounded potential for profits.
They did this last time.
Just a shame the market's closed on the 1st of April.
What I'm going to for the next 4 days when no shares in SAR can be traded. (Cold Turkey).
ATVB
ZA
RE: Maybe
28 Mar '13
Rat. Thanks. A short would only push the sp down further once placed so it wouldnt matter to them as they would be covered either way. As they haven't, there has been no real drop as a result.
Im still erring towards it being a good sign. They are willing to risk it when they could have broken even or made a small profit. At a guess, they suspect they can sell at a higher price than now. otherwise they would mitigate. Imo etc. If the cash is just to be used for working capital, it does secure funds into 2014. But with Zylos posts on phase 1 costs and with these being split 3 ways, it does possibly suggest phase 1 trials for CHK1 (and therefore no CHK1 deal). More risk (2 in 3 fail phase 1). More rewards. What price would we be at after successful trials? The eternal question of risk v reward. GLA
RE: Hopkirk
28 Mar '13
50sBoy. Its possible but would leave very little left. CHK1 has been worken on for years but SKIL came after and is the future for SAR imo. They keep saying it can be used for other kinase targets so any future discoveries will most likely come from here and have tweeted the potential for this area. Unless Tim is planning on retiring soon I very mich doubt it
RE: Maybe
28 Mar '13
Good point but really no idea either way - I would have thought a short more likely in normal circumstances, and shorting would itself have pushed sp down making it a more profitable tactic but imo obviously. I am as frustrated as many on here but in the silence there are still so many streams of work, more than one of which should bear fruit very soon, and i can't help wondering the silence could be a very good omen. I hope!